Pharmaceutical

Bruker to buy cell biology company PhenomeX for $108m

Bruker has entered into a definitive agreement to acquire functional cell biology company PhenomeX for a total equity value of $108m.

Aug 18, 2023 - 20:00
Bruker to buy cell biology company PhenomeX for $108m
Bruker has entered into a definitive agreement to acquire functional cell biology company PhenomeX for a total equity value of $108m.
Read the original article

Tags:

Previous Article

Coeptis licenses Deverra Therapeutics’ clinical stage assets

Next Article

How competitive intelligence can give pharma companies an edge

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Vertex gets a win as Colorado board leaves cystic fibrosis drug off a list of unaffordable medicines

STAT+: Vertex gets a win as Colorado board leaves cysti...

Dec 9, 2023

STAT+: European regulatory panel weighing against approval of Amylyx’s ALS therapy, company says

STAT+: European regulatory panel weighing against appro...

May 31, 2023

Helsinn and Angelini Pharma renew AULIN and MESULID distribution deal

Helsinn and Angelini Pharma renew AULIN and MESULID di...

May 29, 2024